Results 241 to 250 of about 2,808,349 (298)
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen. [PDF]
EBioMedicineFerreira RC, Reynolds SJ, Capoferri AA, Baker OR, Brown EE, Klock E, Miller J, Lai J, Saraf S, Kirby C, Lynch B, Hackman J, Gowanlock SN, Tomusange S, Jamiru S, Anok A, Kityamuweesi T, Buule P, Bruno D, Martens C, Rose R, Lamers SL, Galiwango RM, Poon AFY, Quinn TC, Prodger JL, Redd AD. +26 moreeuropepmc +1 more sourceIn VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
, 2010 Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki, Chiaki Wakasa-Morimoto, Kevin Brown, Robert G. Ferris, Scott A. Foster, Richard Hazen, Shigeru Miki, Akemi Suyama-Kagitani, Shinobu Kawauchi-Miki, Teruhiko Taishi, Takashi Kawasuji, Brian A. Johns, Mark Underwood, Edward P. Garvey, Akihiko Sato, Tamio Fujiwara +17 moreopenalex +1 more sourceLong-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus
Science, 2014 C. D. Andrews, W. Spreen, H. Mohri, Lee Moss, S. Ford, A. Gettie, K. Russell-Lodrigue, R. Bohm, C. Cheng‐Mayer, Zhi Hong, M. Markowitz, D. Ho +11 moresemanticscholar +1 more sourcePreclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Antimicrobial Agents and Chemotherapy, 2014 C. Fenwick, M. Amad, M. Bailey, R. Bethell, M. Bös, P. Bonneau, M. Cordingley, R. Coulombe, J. Duan, P. Edwards, L. Fader, A. Faucher, M. Garneau, A. Jakalian, S. Kawai, L. Lamorte, S. LaPlante, Laibin Luo, S. Mason, M. Poupart, N. Rioux, P. Schroeder, B. Simoneau, S. Tremblay, Y. Tsantrizos, M. Witvrouw, C. Yoakim +26 moresemanticscholar +1 more source